Literature DB >> 9526807

Hypertriglyceridemia as a cardiovascular risk factor.

M A Austin1, J E Hokanson, K L Edwards.   

Abstract

To determine the relation between plasma triglyceride levels and the risk of incident cardiovascular disease, the semiquantitative techniques of meta-analysis were applied to 17 population-based prospective studies of triglyceride and cardiovascular disease. Sixteen of these studies represented 2,445 events among 46,413 Caucasian men followed for an average period of 8.4 years, and 5 studies represented 439 events among 10,864 Caucasian women followed for an average period of 11.4 years. Univariate relative risk (RR) estimates for incident cardiovascular disease associated with a 1-mmol/L increase in triglyceride was 1.07-1.98 in men, with a summary RR of 1.32 (95% confidence interval [CI]: 1.26-1.39), indicating a 32% increase in disease risk associated with increased triglyceride. In the studies involving women, individual RR estimates for triglyceride were 1.69-2.05, with a summary RR of 1.76 (95% CI: 1.50-2.07), indicating a 76% increase in disease risk associated with increased triglyceride. After adjustment for high-density lipoprotein cholesterol and other risk factors, these risks were decreased to 14% in men and 37% in women but remained statistically significant. Three recent prospective epidemiologic studies have also shown that plasma triglyceride and low-density lipoprotein particle size predict subsequent coronary artery disease in Caucasian populations. Taken together, these studies demonstrate the importance of triglyceride levels as a risk factor for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526807     DOI: 10.1016/s0002-9149(98)00031-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  173 in total

Review 1.  The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?

Authors:  G Wells; D M Herrington
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

Review 2.  Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease.

Authors:  H N Ginsberg
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 2.931

3.  Common problems in the management of hypertriglyceridemia.

Authors:  Michelle A Fung; Jiri J Frohlich
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

4.  Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease.

Authors:  Yating Wang; Li Shen; Danyan Xu
Journal:  Clin Cardiol       Date:  2018-12-21       Impact factor: 2.882

Review 5.  A review of low-carbohydrate ketogenic diets.

Authors:  Eric C Westman; John Mavropoulos; William S Yancy; Jeff S Volek
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 6.  The insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 7.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

8.  Utilization patterns of extended-release niacin in Canada: analysis of an administrative claims database.

Authors:  Marc Dorais; Diana Chirovsky; Baishali Ambegaonkar; Vasilisa Sazonov; Glenn Davies; Susan Grant; Jacques Lelorier
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

9.  Using apolipoprotein B to manage dyslipidemic patients: time for a change?

Authors:  Charles R Harper; Terry A Jacobson
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

10.  Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion.

Authors:  Judy A Butler; Tory M Hagen; Régis Moreau
Journal:  Arch Biochem Biophys       Date:  2009-02-20       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.